Dianthus Therapeutics, Inc. /DE/ (DNTH) › Capital ExpendituresDianthus Therapeutics, Inc. /DE/ (DNTH) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2016: $139.0K2017: $2.20M2018: $7.67M2019: $3.06M2020: $400.0K2021: $1.26M2022: $314.0K$314.0K2016Capital Expenditures (USD)2022Fiscal YearCapital ExpendituresChange YoY2022$314.0K-75.2%2021$1.26M+216.0%2020$400.0K-86.9%2019$3.06M-60.1%2018$7.67M+248.9%2017$2.20M+1482.0%2016$139.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share